PARP inhibitor News
Most Popular PARP inhibitor Story
PARP inhibitor posts impressive tumor results
An experimental cancer therapy that's one of a new class of PARP inhibitors produced some surprisingly positive results in a small study of cancer victims who share BRCA1 and BRCA2 genetic mutations. Read more...
Latest Headlines
- June 25, 2009
- June 1, 2009
- April 8, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
